| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | empagliflozin | FAERS: 2 | US FAERS | |
| 2 | Canagliflozin | FAERS: 1 | US FAERS | |
| 3 | Mifepristone | FAERS: 1 | US FAERS | |
| 4 | Sorafenib | FAERS: 1 | US FAERS | |
| 5 | Sunitinib | FAERS: 1 | US FAERS | |
| 6 | Synjardy | FAERS: 1 | US FAERS | |
| 7 | Varenicline | FAERS: 1 | US FAERS | |
| 8 | apixaban | FAERS: 1 | US FAERS | |
| 9 | Scopolamine | OFFSIDES | ||
| 10 | Tazobactam | OFFSIDES | ||
| 11 | binedaline | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.